Jennifer Anderson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jennifer Anderson has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Patrick MacInnis
Department of Otolaryngology – Head and Neck Surgery, Temerty Faculty of Medicine University of Toronto, Unity Health Toronto – St. Michael's Hospital Toronto Ontario Canada
3 shared publicationsPeter Y. F. Zeng
Department of Otolaryngology – Head and Neck Surgery Western University London Ontario Canada
3 shared publicationsAmir H. Karimi
Department of Otolaryngology—Head and Neck Surgery Western University London Ontario Canada
2 shared publications- Anthony Charles Nichols
Department of Otolaryngology—Head and Neck Surgery, Western University, London, ON, Canada
2 shared publications Halema Khan
Department of Otolaryngology—Head and Neck Surgery Western University London Ontario Canada
2 shared publicationsHarrison Pan
Department of Otolaryngology—Head and Neck Surgery Western University London Ontario Canada
2 shared publications
Latest Publications
- Open Access
- 29 June 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (11) , 4914-4920
Awake Blue Light vs. KTP Laser Treatment for Vocal Fold Lesions: A Randomized Controlled Trial
Objective: To compare clinical outcomes of a 445‐nm blue light (BL) laser with the established 532‐nm potassium titanyl phosphate (KTP) laser for office‐based treatment of benign vocal fold lesions. Methods: In this parallel‐group, open‐label randomized controlled trial, adults (≥ 18 years) with benign vocal fold lesions underwent baseline VHI‐10 and laryngeal stroboscopy, followed by in‐office laser treatment. Pain visual analogue scale (VAS) scores were collected at baseline and daily for 7 days after the procedure. The primary outcome was the between‐group difference in the change in Voice Handicap Index‐10 (VHI‐10) scores. Secondary outcomes included between‐group comparisons of post‐procedural pain and stroboscopic parameters at 90 days after treatment. Linear mixed‐effects model assessed changes in VHI‐10 and pain VAS over time, while Cochran–Mantel–Haenszel and logistic regression tests compared stroboscopy outcomes. Results: Ninety‐eight patients were enrolled (49 per group). Baseline characteristics were similar aside from a slightly younger age in the KTP group ( p = 0.048). VHI‐10 scores improved significantly in both groups at postoperative day (POD)7 (−5.98), POD30 (−9.28), and POD90 (−12.43) (all p ≤ 0.001), with no between‐group differences ( p = 0.596). Pain decreased significantly over time ( p < 0.001), without group differences ( p = 0.47). At POD90, complete vocal fold closure occurred in 91.2% (BL) and 85.7% (KTP) of patients ( p = 0.74). Normal mucosal wave was observed in 79.4% (BL) and 81.0% (KTP), with no significant differences. Conclusion: BL laser demonstrated clinical outcomes comparable to KTP, with similar voice improvement, pain reduction, and stroboscopic results. Level of Evidence: 2
- 29 June 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (11) , 4914-4920
Open AccessAwake Blue Light vs. KTP Laser Treatment for Vocal Fold Lesions: A Randomized Controlled Trial
Objective: To compare clinical outcomes of a 445‐nm blue light (BL) laser with the established 532‐nm potassium titanyl phosphate (KTP) laser for office‐based treatment of benign vocal fold lesions. Methods: In this parallel‐group, open‐label randomized controlled trial, adults (≥ 18 years) with benign vocal fold lesions underwent baseline VHI‐10 and laryngeal stroboscopy, followed by in‐office laser treatment. Pain visual analogue scale (VAS) scores were collected at baseline and daily for 7 days after the procedure. The primary outcome was the between‐group difference in the change in Voice Handicap Index‐10 (VHI‐10) scores. Secondary outcomes included between‐group comparisons of post‐procedural pain and stroboscopic parameters at 90 days after treatment. Linear mixed‐effects model assessed changes in VHI‐10 and pain VAS over time, while Cochran–Mantel–Haenszel and logistic regression tests compared stroboscopy outcomes. Results: Ninety‐eight patients were enrolled (49 per group). Baseline characteristics were similar aside from a slightly younger age in the KTP group ( p = 0.048). VHI‐10 scores improved significantly in both groups at postoperative day (POD)7 (−5.98), POD30 (−9.28), and POD90 (−12.43) (all p ≤ 0.001), with no between‐group differences ( p = 0.596). Pain decreased significantly over time ( p < 0.001), without group differences ( p = 0.47). At POD90, complete vocal fold closure occurred in 91.2% (BL) and 85.7% (KTP) of patients ( p = 0.74). Normal mucosal wave was observed in 79.4% (BL) and 81.0% (KTP), with no significant differences. Conclusion: BL laser demonstrated clinical outcomes comparable to KTP, with similar voice improvement, pain reduction, and stroboscopic results. Level of Evidence: 2
- Open Access
- 6 May 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (9) , 3273-3279
Transcriptomic Features of Recurrence Rates in Idiopathic Subglottic Stenosis
Objective: Idiopathic subglottic stenosis (iSGS) is a rare disease characterized by narrowing of the upper airway and affects near‐exclusively females. Patients often experience recurrent disease and require repeated surgical dilations. The pathophysiology underlying the broad spectrum of disease severity within iSGS remains unknown. In the current study, we sought to identify transcriptomic differences between iSGS patients with markedly different recurrence rates.Methods: Prospectively collected clinical and bulk RNA sequencing data from subglottic tissues of 56 female iSGS patients with 1–4 years of follow‐up were analyzed. DESeq2 was used to perform differential expression analysis, comparing samples from the highest (1.19–1.87 dilations/year) versus the lowest (0.30–0.65 dilations/year) quartile of surgical dilation rate (i.e., high vs. low recurrence groups).Results: In total, 220 genes were significantly differentially expressed between the high and low recurrence groups (adjusted p < 0.1 and log2 fold change > |1|). Pathway enrichment analyses showed that the high recurrence group had significantly increased expression of genes involved in adaptive immune responses (e.g., immunoglobulin subunit genes) and extracellular matrix organization (e.g., COMP, NID2) (adjusted p < 0.1). In contrast, the low recurrence group had significantly increased expression of genes involved in cilia structure and function (e.g., CFAP43, DNAI2) (adjusted p < 0.1), suggesting a relatively increased abundance of respiratory cilia.Conclusion: Transcriptomic profiling suggests that lower recurrence rates in iSGS are associated with retention of respiratory cilia, while adaptive immune responses and increased extracellular matrix deposition are present in those with higher recurrence rates. These results hold promise for the development of prognostic markers and identification of therapeutic targets for iSGS.
- 6 May 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (9) , 3273-3279
Open AccessTranscriptomic Features of Recurrence Rates in Idiopathic Subglottic Stenosis
Objective: Idiopathic subglottic stenosis (iSGS) is a rare disease characterized by narrowing of the upper airway and affects near‐exclusively females. Patients often experience recurrent disease and require repeated surgical dilations. The pathophysiology underlying the broad spectrum of disease severity within iSGS remains unknown. In the current study, we sought to identify transcriptomic differences between iSGS patients with markedly different recurrence rates.Methods: Prospectively collected clinical and bulk RNA sequencing data from subglottic tissues of 56 female iSGS patients with 1–4 years of follow‐up were analyzed. DESeq2 was used to perform differential expression analysis, comparing samples from the highest (1.19–1.87 dilations/year) versus the lowest (0.30–0.65 dilations/year) quartile of surgical dilation rate (i.e., high vs. low recurrence groups).Results: In total, 220 genes were significantly differentially expressed between the high and low recurrence groups (adjusted p < 0.1 and log2 fold change > |1|). Pathway enrichment analyses showed that the high recurrence group had significantly increased expression of genes involved in adaptive immune responses (e.g., immunoglobulin subunit genes) and extracellular matrix organization (e.g., COMP, NID2) (adjusted p < 0.1). In contrast, the low recurrence group had significantly increased expression of genes involved in cilia structure and function (e.g., CFAP43, DNAI2) (adjusted p < 0.1), suggesting a relatively increased abundance of respiratory cilia.Conclusion: Transcriptomic profiling suggests that lower recurrence rates in iSGS are associated with retention of respiratory cilia, while adaptive immune responses and increased extracellular matrix deposition are present in those with higher recurrence rates. These results hold promise for the development of prognostic markers and identification of therapeutic targets for iSGS.
- Open Access
- 16 April 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (9) , 3265-3272
Effect of Serial Intralesional Steroid Injections on Risk of Recurrence in Idiopathic Subglottic Stenosis
Background: Serial intralesional steroid injections (ILSIs) have been suggested to be an effective adjunct treatment for idiopathic subglottic stenosis (iSGS) by maintaining airway patency and extending inter‐surgical intervals. However, evidence for the effectiveness of serial ILSIs remains inconclusive. The current study aimed to assess whether ILSIs reduce the risk of subsequent surgical dilation (i.e., recurrence) in a cohort of patients with iSGS.Methods: Prospectively collected clinical data for 75 female iSGS patients with 1–4 years of follow‐up were analyzed. To assess the effect of ILSI use on the risk of recurrence, we assessed both the time‐to‐first recurrence using a standard Cox proportional hazards model and all recurrences per patient using a recurrent‐events model. Overall, there were 36 patients who had received ILSIs at any point in the follow‐up period and 39 patients who had not.Results: ILSI use was associated with a significantly reduced risk of recurrence in both time‐to‐first event (hazard ratio (HR) = 0.20, 95% confidence interval (CI) 0.08–0.49) and recurrent events (HR = 0.44, 95% CI 0.26–0.75) multivariate Cox proportional hazard models, along with older age at diagnosis and longer time since diagnosis (all p < 0.05). In the time‐to‐first event analysis, the median time to recurrence among those who had received ILSIs was 2.5 years compared to 1.4 years among those who had not. The number needed to treat with ILSIs to avoid one recurrence by 2 years follow‐up was two.Conclusion: Serial ILSIs were associated with reduced risk of recurrence, along with older age at diagnosis and longer time since diagnosis.Level of Evidence: 3 (non‐randomized controlled cohort/follow‐up study).
- 16 April 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (9) , 3265-3272
Open AccessEffect of Serial Intralesional Steroid Injections on Risk of Recurrence in Idiopathic Subglottic Stenosis
Background: Serial intralesional steroid injections (ILSIs) have been suggested to be an effective adjunct treatment for idiopathic subglottic stenosis (iSGS) by maintaining airway patency and extending inter‐surgical intervals. However, evidence for the effectiveness of serial ILSIs remains inconclusive. The current study aimed to assess whether ILSIs reduce the risk of subsequent surgical dilation (i.e., recurrence) in a cohort of patients with iSGS.Methods: Prospectively collected clinical data for 75 female iSGS patients with 1–4 years of follow‐up were analyzed. To assess the effect of ILSI use on the risk of recurrence, we assessed both the time‐to‐first recurrence using a standard Cox proportional hazards model and all recurrences per patient using a recurrent‐events model. Overall, there were 36 patients who had received ILSIs at any point in the follow‐up period and 39 patients who had not.Results: ILSI use was associated with a significantly reduced risk of recurrence in both time‐to‐first event (hazard ratio (HR) = 0.20, 95% confidence interval (CI) 0.08–0.49) and recurrent events (HR = 0.44, 95% CI 0.26–0.75) multivariate Cox proportional hazard models, along with older age at diagnosis and longer time since diagnosis (all p < 0.05). In the time‐to‐first event analysis, the median time to recurrence among those who had received ILSIs was 2.5 years compared to 1.4 years among those who had not. The number needed to treat with ILSIs to avoid one recurrence by 2 years follow‐up was two.Conclusion: Serial ILSIs were associated with reduced risk of recurrence, along with older age at diagnosis and longer time since diagnosis.Level of Evidence: 3 (non‐randomized controlled cohort/follow‐up study).
- Open Access
- 1 October 2024
- Published by Wiley in The Laryngoscope
- Vol. 135 (2) , 758-762
Prospective Evaluation of Abelchia/RCPD Patients: Abnormalities in High‐Resolution Esophageal Manometry
Self‐diagnosis of retrograde cricopharyngeus dysfunction (RCPD) or abelchia has been increasing over the past 5 years with patients seeking treatment for lifelong symptoms of inability to burp, neck gurgling, bloating, and flatulence. There is a distinct paucity of objective data in diagnosis and underlying pathophysiology of this disorder.Objective: The purpose of this study was to prospectively evaluate patients with abelchia using standardized investigations to explore possible underlying mechanisms.Methods: Patients presenting with clinical scenario consistent with RCPD were recruited into the study after informed consent. All patients underwent standardized investigations: Self reporting questionnaires EAT‐10, VHI‐10, and RSI scores, as well as esophagogastroscopy, barium swallow, and high‐resolution esophageal manometry (HRM), were performed.Results: RCPD patients demonstrated a minor increase in the mean EAT‐10 (5.2 ± 1.2) and normal RSI/VHI‐10 scores. Barium swallow revealed 53% (CI 38%–64%) were abnormal with reflux with hiatus hernia (37%) and dysmotility (16%) as most common findings.HRM showed that 67% (CI 54%–78%) were abnormal. Ineffective motility was found in 41%, a further 23% showed a complete absence of peristalsis, whereas 33% were normal.Conclusions: RCPD is a clinical condition of lifelong inability to belch and associated symptoms. The underlying pathophysiology is poorly understood. This study demonstrates that a significant number of RCPD patients have abnormal esophageal neural network with high proportion of abnormal or absent esophageal peristalsis.Level of Evidence: 3 Laryngoscope, 135:758–762, 2025
- 1 October 2024
- Published by Wiley in The Laryngoscope
- Vol. 135 (2) , 758-762
Open AccessProspective Evaluation of Abelchia/RCPD Patients: Abnormalities in High‐Resolution Esophageal Manometry
Self‐diagnosis of retrograde cricopharyngeus dysfunction (RCPD) or abelchia has been increasing over the past 5 years with patients seeking treatment for lifelong symptoms of inability to burp, neck gurgling, bloating, and flatulence. There is a distinct paucity of objective data in diagnosis and underlying pathophysiology of this disorder.Objective: The purpose of this study was to prospectively evaluate patients with abelchia using standardized investigations to explore possible underlying mechanisms.Methods: Patients presenting with clinical scenario consistent with RCPD were recruited into the study after informed consent. All patients underwent standardized investigations: Self reporting questionnaires EAT‐10, VHI‐10, and RSI scores, as well as esophagogastroscopy, barium swallow, and high‐resolution esophageal manometry (HRM), were performed.Results: RCPD patients demonstrated a minor increase in the mean EAT‐10 (5.2 ± 1.2) and normal RSI/VHI‐10 scores. Barium swallow revealed 53% (CI 38%–64%) were abnormal with reflux with hiatus hernia (37%) and dysmotility (16%) as most common findings.HRM showed that 67% (CI 54%–78%) were abnormal. Ineffective motility was found in 41%, a further 23% showed a complete absence of peristalsis, whereas 33% were normal.Conclusions: RCPD is a clinical condition of lifelong inability to belch and associated symptoms. The underlying pathophysiology is poorly understood. This study demonstrates that a significant number of RCPD patients have abnormal esophageal neural network with high proportion of abnormal or absent esophageal peristalsis.Level of Evidence: 3 Laryngoscope, 135:758–762, 2025
- Open Access
- 2 September 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (2) , 803-806
Environmental Sustainability: Waste Audit Comparison Operating Roomand In‐Office Laryngeal Surgery
Introduction With vast improvements in imaging and endoscopic technology, there has been a massive shift towards in office procedures for various laryngeal disorders with significant health system and patient benefits. Another benefit which has yet to be investigated is the potential environmental effects and waste reduction of in-office laryngeal procedures over traditional operating room surgery.Objectives The purpose of this study is to perform a waste audit and compare the results between operating room and in-office laser laryngeal surgery.Methods Ten cases of in-office and operating room laser laryngeal surgery, performed for recurrent respiratory papillomatosis, were subjected to a waste audit with four waste streams identified. Recyclable, general waste, anesthesia source and sharps. All waste was included from the time of case preparation to termination.Results The cases were extremely homogeneous in the waste produced. The mean waste total produced for the operating room laser surgery was 2972 g of which 18% was recoverable/recyclable. Contamination rate was very low. Recycling was performed very well by nursing/prep staff; however, anesthesia was not recovering 13% of potential materials. The in-office waste produced was approximately one tenth of the operating room waste with almost all delegated into general waste. Potentially divertible/recyclable materials accounted for 38% of the waste in-office procedures.Conclusions In-office laryngeal procedures produce 13% of waste compared to surgery performed for similar pathology. These procedures are cost effective, safe and have been demonstrated to enhance environmental sustainability.
- 2 September 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (2) , 803-806
Open AccessEnvironmental Sustainability: Waste Audit Comparison Operating Roomand In‐Office Laryngeal Surgery
Introduction With vast improvements in imaging and endoscopic technology, there has been a massive shift towards in office procedures for various laryngeal disorders with significant health system and patient benefits. Another benefit which has yet to be investigated is the potential environmental effects and waste reduction of in-office laryngeal procedures over traditional operating room surgery.Objectives The purpose of this study is to perform a waste audit and compare the results between operating room and in-office laser laryngeal surgery.Methods Ten cases of in-office and operating room laser laryngeal surgery, performed for recurrent respiratory papillomatosis, were subjected to a waste audit with four waste streams identified. Recyclable, general waste, anesthesia source and sharps. All waste was included from the time of case preparation to termination.Results The cases were extremely homogeneous in the waste produced. The mean waste total produced for the operating room laser surgery was 2972 g of which 18% was recoverable/recyclable. Contamination rate was very low. Recycling was performed very well by nursing/prep staff; however, anesthesia was not recovering 13% of potential materials. The in-office waste produced was approximately one tenth of the operating room waste with almost all delegated into general waste. Potentially divertible/recyclable materials accounted for 38% of the waste in-office procedures.Conclusions In-office laryngeal procedures produce 13% of waste compared to surgery performed for similar pathology. These procedures are cost effective, safe and have been demonstrated to enhance environmental sustainability.
- Open Access
- 20 June 2020
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 154 (4) , 486-493
Data-Driven Development of an Institutional “Gross-Only” Policy for the Examination of Select Surgical Pathology Specimens
Objectives: To determine diagnostic, workflow, and economic implications of instituting a gross-only policy at our institution.Methods: Retrospective (2017) key word searches were performed to identify “gross-only” cases for which microscopic evaluation could potentially be omitted, but was performed, and those who underwent gross evaluation per surgeon request. Cases were evaluated for type(s), part(s), block volume, turnaround time, demographics, and diagnosis. Laboratory costs and reimbursement were evaluated.Results: In total, 448 potential gross-only cases with 472 specimens consisted of atherosclerotic plaques (33.5%), bariatric stomach/bowel (32.6%), hernia (15.7%), heart valves (12.7%), and other (5.9%). Four (2.6%) bariatric surgery cases had Helicobacter pylori infection; these were the only cases with “significant” histologic findings. Cost analysis revealed that converting all potential gross-only specimens to gross only would result in overall losses based on average reimbursements, most influenced by bariatric specimens (Current Procedural Terminology code 88307), comprising 65.2% of estimated loss.Conclusions: Establishing a gross-only policy should be guided by established recommendations but institutionally individualized and data driven. It was reasonable for us to establish a gross-only policy for most evaluated specimens, while excluding bariatric stomach specimens in which microscopic pathology could be missed, given the lack of H pylori screening at our institution.
- 20 June 2020
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 154 (4) , 486-493
Open AccessData-Driven Development of an Institutional “Gross-Only” Policy for the Examination of Select Surgical Pathology Specimens
Objectives: To determine diagnostic, workflow, and economic implications of instituting a gross-only policy at our institution.Methods: Retrospective (2017) key word searches were performed to identify “gross-only” cases for which microscopic evaluation could potentially be omitted, but was performed, and those who underwent gross evaluation per surgeon request. Cases were evaluated for type(s), part(s), block volume, turnaround time, demographics, and diagnosis. Laboratory costs and reimbursement were evaluated.Results: In total, 448 potential gross-only cases with 472 specimens consisted of atherosclerotic plaques (33.5%), bariatric stomach/bowel (32.6%), hernia (15.7%), heart valves (12.7%), and other (5.9%). Four (2.6%) bariatric surgery cases had Helicobacter pylori infection; these were the only cases with “significant” histologic findings. Cost analysis revealed that converting all potential gross-only specimens to gross only would result in overall losses based on average reimbursements, most influenced by bariatric specimens (Current Procedural Terminology code 88307), comprising 65.2% of estimated loss.Conclusions: Establishing a gross-only policy should be guided by established recommendations but institutionally individualized and data driven. It was reasonable for us to establish a gross-only policy for most evaluated specimens, while excluding bariatric stomach specimens in which microscopic pathology could be missed, given the lack of H pylori screening at our institution.
- Open Access
- 1 January 2020
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 49 (1) , 1-7
The role of steroid injection for vocal folds lesions in professional voice users
Background: Benign vocal fold lesions identified in professional voice users, frequently require further treatment after failure of conservative measures. The role of vocal fold steroid injection as a treatment option for select benign lesions is the focus of this study. Steroid injection may avoid phonosurgery in some individuals thereby reducing the potential for adverse side effects associated with surgery. Objective: The purpose of the study is to review the effect of steroid injection on vocal function in professional voice users associated with a benign lesion(s) using the Voice Handicap Index-10. Method: This study is a retrospective review of patients (professional voice users) that underwent 1 or more steroid injection(s) between July 2014-December 2018. The Voice Handicap Index-10 was compared from pre to post treatment. Patients were identified using billing code data for laryngeal injection. Patient demographics (age, gender, profession), previous phonosurgery, date of steroid injection and follow up dates as well as VHI-10 scores were collected from the electronic medical record. Results: Twenty four patients were identified. The mean Voice HandicapIndex-10 score decreased from 23.5 pre injection to 17.8 post injection which represented a reduction of 24.3%. Vocal fold steroid injection procedure in our series was associated with one complication. Conclusion: Vocal fold steroid injection for benign lesions is a safe, well-tolerated procedure with an improvement in vocal function without surgical intervention. Steroid injection should be considered as a treatment option to avoid surgery in patients with select vocal fold lesions.
- 1 January 2020
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 49 (1) , 1-7
Open AccessThe role of steroid injection for vocal folds lesions in professional voice users
Background: Benign vocal fold lesions identified in professional voice users, frequently require further treatment after failure of conservative measures. The role of vocal fold steroid injection as a treatment option for select benign lesions is the focus of this study. Steroid injection may avoid phonosurgery in some individuals thereby reducing the potential for adverse side effects associated with surgery. Objective: The purpose of the study is to review the effect of steroid injection on vocal function in professional voice users associated with a benign lesion(s) using the Voice Handicap Index-10. Method: This study is a retrospective review of patients (professional voice users) that underwent 1 or more steroid injection(s) between July 2014-December 2018. The Voice Handicap Index-10 was compared from pre to post treatment. Patients were identified using billing code data for laryngeal injection. Patient demographics (age, gender, profession), previous phonosurgery, date of steroid injection and follow up dates as well as VHI-10 scores were collected from the electronic medical record. Results: Twenty four patients were identified. The mean Voice HandicapIndex-10 score decreased from 23.5 pre injection to 17.8 post injection which represented a reduction of 24.3%. Vocal fold steroid injection procedure in our series was associated with one complication. Conclusion: Vocal fold steroid injection for benign lesions is a safe, well-tolerated procedure with an improvement in vocal function without surgical intervention. Steroid injection should be considered as a treatment option to avoid surgery in patients with select vocal fold lesions.